Sclerosis of Lytic Bone Metastases After Disodium Aminohydroxypropylidene Bisphosphonate (APD) in Patients With Breast Carcinoma.

BMJ

doi 10.1136/bmj.297.6651.772

Full Text

Abstract

Available in

Date

September 24, 1988

Authors

Publisher

BMJ

Related search

Prognostic Significance of Bone Metastases and Bisphosphonate Therapy in Patients With Renal Cell Carcinoma

European Urology

English

Pharmacotherapy With Pamidronate Disodium of Osteolytic Bone Metastases of Breast Cancer, Osteolytic Lesions of Multiple Myeloma, and Paget's Disease

Clinical Medicine. Therapeutics

English

Enhancing Quality of Life for Breast Cancer Patients With Bone Metastases

English

Analysis of Orthopedic Surgery of Bone Metastases in Breast Cancer Patients

BMC Musculoskeletal Disorders

Sports Medicine

English

Micrometastases in Bone Marrow in Patients With Primary Breast Cancer: Evaluation as an Early Predictor of Bone Metastases.

English

Bilateral Orbital Metastases in a Woman With Breast Carcinoma

Journal of the Royal Society of Medicine

English

Bone Health in Patients With Multiple Sclerosis

Journal of Osteoporosis

English

Complete Remission of Bone Metastases in Renal Cell Carcinoma With Nivolumab

English

MSX-1 Is Suppressed in Bisphosphonate-Exposed Jaw Bone Analysis of Bone Turnover-Related Cell Signalling After Bisphosphonate Treatment

Otorhinolaryngology

English